Wolverine Asset Management LLC raised its position in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 496.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 187,617 shares of the company’s stock after acquiring an additional 156,141 shares during the quarter. Wolverine Asset Management LLC’s holdings in BlackRock Health Sciences Term Trust were worth $2,702,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of BMEZ. Dakota Wealth Management grew its position in shares of BlackRock Health Sciences Term Trust by 23.4% during the third quarter. Dakota Wealth Management now owns 22,509 shares of the company’s stock worth $357,000 after buying an additional 4,267 shares in the last quarter. Oppenheimer & Co. Inc. grew its position in shares of BlackRock Health Sciences Term Trust by 0.6% during the third quarter. Oppenheimer & Co. Inc. now owns 204,354 shares of the company’s stock worth $3,237,000 after buying an additional 1,153 shares in the last quarter. Penserra Capital Management LLC acquired a new stake in shares of BlackRock Health Sciences Term Trust during the third quarter worth approximately $15,390,000. Brown Brothers Harriman & Co. acquired a new stake in shares of BlackRock Health Sciences Term Trust during the third quarter worth approximately $32,000. Finally, Stifel Financial Corp grew its position in shares of BlackRock Health Sciences Term Trust by 2.2% during the third quarter. Stifel Financial Corp now owns 414,346 shares of the company’s stock worth $6,563,000 after buying an additional 8,843 shares in the last quarter.
BlackRock Health Sciences Term Trust Price Performance
BMEZ stock opened at $15.87 on Friday. BlackRock Health Sciences Term Trust has a twelve month low of $14.27 and a twelve month high of $16.75. The firm has a 50 day simple moving average of $15.57 and a 200-day simple moving average of $15.68.
BlackRock Health Sciences Term Trust Announces Dividend
BlackRock Health Sciences Term Trust Profile
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Featured Stories
- Five stocks we like better than BlackRock Health Sciences Term Trust
- The 3 Best Blue-Chip Stocks to Buy Now
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- Want to Profit on the Downtrend? Downtrends, Explained.
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- Which Wall Street Analysts are the Most Accurate?
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.